TAKP34:BVMF
Takeda Pharmaceutical Company
99,07 BRL
arrow_upward
+1,33%(+1,30) 1D
28. ruj, 20:23:55 GMT -3 · BRL
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za TAKP34...
Trž. kap.
9,04 bil.
Prosj. kol.
36,00
Količina
0,00
52-tjed. najviša
99,07 BRL
52-tjed. najniža
70,80 BRL
Dionice u optjecaju
1,60 mlr.
Broj djelatnika
47 tis.
Trž. kap.
9,04 bil.
Prosj. kol.
36,00
Količina
0,00
52-tjed. najviša
99,07 BRL
52-tjed. najniža
70,80 BRL
Dionice u optjecaju
1,60 mlr.
Broj djelatnika
47 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
TipRanks
·
prije 14 sati
Takeda Refines VPRIV Home Infusion Playbook With New EU Survey
Yahoo Finance
·
prije 15 sati
Corus International Receives $6.4 Million Grant From Takeda to Reduce Climate-Related Health Risks in Nepal
Profil
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
Takeda Pharmaceutical Company – informacije
Glavni izvršni direktorChristophe Weber | Christophe Weber
Zaposlenici47 tis.
Osnovano12. lip 1781.
Sjedište-
Sektor-
Web-lokacijatakeda.com